Waystar (WAY) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
29 Jul, 2026Executive summary
Q2 2026 revenue reached $320 million, up 18% year-over-year, with adjusted EBITDA of $137 million and a 43% margin, and net income of $40.9 million, exceeding consensus expectations.
Strong client growth with 1,453 clients generating over $100,000 in trailing 12-month revenue, up 15% year-over-year, driven by large provider organizations and demand for AI-powered solutions.
Over 99% of revenue is recurring, supported by robust subscription and volume-based fees, with net revenue retention at 108%.
Platform consolidation and AI-powered solutions are accelerating, with providers seeking integrated offerings and significant ROI.
Announced CFO transition: Steve Oreskovich to advisor role, Alpana Wegner appointed as new CFO.
Financial highlights
Q2 2026 revenue was $319.7 million, up 18.1% year-over-year, with adjusted EBITDA of $136.7 million and a 43% margin.
Subscription revenue reached $176.3 million (34% year-over-year growth), 55% of total revenue; volume-based revenue was $142.1 million, up 3%.
Net income for Q2 2026 was $40.9 million, with diluted EPS of $0.21.
Unlevered free cash flow for Q2 was $63.9 million, with a 57% conversion rate from adjusted EBITDA.
Ended quarter with $12.6 million in cash, $179 million in investment securities, and $1.47 billion in total debt.
Outlook and guidance
Full-year 2026 revenue guidance raised to $1.276–$1.294 billion (midpoint $1.285 billion, 17% year-over-year growth).
Adjusted EBITDA guidance increased to $535–$545 million (midpoint $540 million), with margin guidance at 42%.
Non-GAAP net income forecasted at $322–$340 million, with diluted non-GAAP EPS of $1.61–$1.70.
Continued investment in AI and automation, balancing margin expansion with growth initiatives.
Seasonality expected in Q4 due to patient deductible dynamics; visibility into 2027 revenue from large deals and cross-sell opportunities.
Latest events from Waystar
- AI-powered automation and data integration drive efficiency, growth, and industry leadership.WAY
46th Annual William Blair Growth Stock Conference - All board proposals passed, including director elections and annual say-on-pay votes.WAY
AGM 2026 - Q1 2026 revenue rose 22% to $313.9M, with a 43% adjusted EBITDA margin and strong AI-driven growth.WAY
Q1 2026 - Q2 revenue rose 15% to $270.7M, guidance was raised, and a $1.25B acquisition was announced.WAY
Q2 2025 - $1.25B AI-driven deal expands market by 15% and targets $15M+ in cost synergies.WAY
M&A Announcement - Q3 revenue up 22% to $240.1M, 40% EBITDA margin, $1B+ IPO, and raised full-year guidance.WAY
Q3 2024 - Q2 revenue up 20% to $234.5M, with strong margins and $1B+ debt reduction post-IPO.WAY
Q2 2024 - AI-driven healthcare payments platform achieves strong growth and industry leadership.WAY
43rd Annual J.P. Morgan Healthcare Conference 2025 - 2024 revenue up 19%, EBITDA margin 40.6%, net leverage 2.8x; 2025 targets 10% normalized growth.WAY
Q4 2024